GTG price jumps on Applera lawsuit news
Thursday, 16 September, 2004
The share price of Genetic Technologies (ASX: GTG) jumped 25 per cent today on heavy trading after the company announced that the judge in GTG's lawsuit against Applera had ruled largely in the company's favour during the Markman hearing, in which the court rules on the precise meanings of certain disputed technical terms within GTG's patent claims.
Out of 15 disputed terms, the court ruled in favour of GTG's definition in 13 cases, and for the remaining two terms, the court adopted a definition consistent with GTG's position.
At the time of writing, GTG's shares were trading at AUD$0.475, up from a previous close of $0.38.
Widespread resistance to common antibiotics is increasing: WHO
Increasing resistance to essential antibiotics poses a growing threat to global health, with one...
Dopamine helps our brains to let go of memories
In a discovery that could reshape how we think about memory, researchers at Flinders University...
Vaccine for elephant herpesvirus found to be safe
The vaccine could prevent deadly elephant endotheliotropic herpesvirus in calves — the...
